Učitavanje...
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients
Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a serious risk that faces diabetic patients who fast during Ramadan (the 9th month in the Islamic calendar). New glucose-lowering classes like dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like pep...
Spremljeno u:
| Izdano u: | J Diabetes Res |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013205/ https://ncbi.nlm.nih.gov/pubmed/27642611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6962574 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|